
Opinion|Videos|January 8, 2025
Safety Considerations When Initiating Treatment for PBC
Panelists discuss how safety considerations for primary biliary cholangitis (PBC) treatment include monitoring liver function tests, managing pruritus and fatigue, assessing drug interactions, and evaluating individual patient factors like pregnancy status and comorbidities, which all influence the choice between ursodeoxycholic acid and second-line therapies.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the primary safety considerations when initiating treatment for primary biliary cholangitis, and how do these considerations influence initial therapy selection?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Amid Mounting Pressure, FDA Commissioner Marty Makary to Resign
3
From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management
4
Q&A: Pharmacist-Led Strategies to Improve Diabetes Outcomes and Lower Costs
5
































































































































